Have a feature idea you'd love to see implemented?
Let us know!
QURE uniQure NV
Price (delayed)
$18.005
Market cap
$877.62M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.96
Enterprise value
$1.12B
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
Highlights
The debt fell by 8% QoQ and by 5% YoY
The gross profit has plunged by 98% YoY but it has soared by 73% from the previous quarter
The gross margin has dropped by 92% year-on-year but it has soared by 67% since the previous quarter
The equity has shrunk by 79% YoY and by 43% QoQ
The quick ratio is down by 36% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of QURE
Market
Valuations
Earnings
Shares outstanding
48.74M
Market cap
$877.62M
Enterprise value
$1.12B
Price to earnings (P/E)
N/A
Price to book (P/B)
15.71
Price to sales (P/S)
30.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
39.19
Revenue
$28.59M
Gross profit
$2.04M
Net income
-$239.5M
EBIT
-$170.32M
EBITDA
-$157.85M
Free cash flow
-$193.09M
Per share
Balance sheet
Liquidity
EPS
-$4.96
EPS diluted
-$4.96
Free cash flow per share
-$3.96
Book value per share
$1.15
Revenue per share
$0.59
TBVPS
$11.19
Total assets
$645.81M
Total liabilities
$589.99M
Debt
$494.28M
Equity
$55.82M
Working capital
$392.87M
Debt to equity
8.85
Current ratio
6.51
Quick ratio
6.18
Net debt/EBITDA
-1.54
Margins
Efficiency
Dividend
EBITDA margin
-552.2%
Gross margin
7.2%
Net margin
-837.8%
Operating margin
-700.4%
Return on assets
-32.2%
Return on equity
-188.8%
Return on invested capital
-19.9%
Return on capital employed
-29.6%
Return on sales
-595.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QURE stock price
How has the uniQure stock price performed over time
Intraday
1.95%
1 week
1.55%
1 month
152.52%
1 year
159.81%
YTD
1.95%
QTD
1.95%
Financial performance
How have uniQure's revenue and profit performed over time
Revenue
$28.59M
Gross profit
$2.04M
Operating income
-$200.21M
Net income
-$239.5M
Gross margin
7.2%
Net margin
-837.8%
The gross profit has plunged by 98% YoY but it has soared by 73% from the previous quarter
The gross margin has dropped by 92% year-on-year but it has soared by 67% since the previous quarter
The company's revenue has shrunk by 74% YoY but it rose by 3.2% QoQ
The operating margin has grown by 20% from the previous quarter
Growth
What is uniQure's growth rate over time
Valuation
What is uniQure stock price valuation
P/E
N/A
P/B
15.71
P/S
30.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
39.19
The company's EPS rose by 16% QoQ but it fell by 3.3% YoY
The equity has shrunk by 79% YoY and by 43% QoQ
The P/S is 141% higher than the last 4 quarters average of 12.5 but 52% lower than the 5-year quarterly average of 62.1
The company's revenue has shrunk by 74% YoY but it rose by 3.2% QoQ
Efficiency
How efficient is uniQure business performance
The return on invested capital has increased by 32% year-on-year and by 15% since the previous quarter
The company's return on sales rose by 24% QoQ
The return on equity has declined by 19% since the previous quarter
The ROA has contracted by 11% YoY but it has grown by 9% from the previous quarter
Dividends
What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QURE.
Financial health
How did uniQure financials performed over time
QURE's total assets is 9% greater than its total liabilities
The current ratio has contracted by 36% YoY and by 12% from the previous quarter
The quick ratio is down by 36% year-on-year and by 7% since the previous quarter
The equity has shrunk by 79% YoY and by 43% QoQ
The debt to equity has soared by 61% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.